FindTrial
Sign In

Anhydrous Enol-oxaloacetate

DRUG2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Mayo Clinic

Conditions

Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8

Phase 1

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
WithdrawnNCT05720624
Mayo ClinicMalignant Central Nervous System Neoplasm
Start: 2025-10-20End: 2025-10-20Updated: 2025-10-22

Phase 2

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
CompletedNCT04290897
Jonsson Comprehensive Cancer CenterAnatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 +14
Start: 2021-09-29End: 2024-11-12Updated: 2025-07-15